EMA Authorised: Tecvayli

View source ↗

Summary

Tecvayli has been authorised in the EU for multiple myeloma with conditional approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• TECVAYLI (TECLISTAMAB-CQYV)

Snippet

Status: Authorised. Therapeutic area: Multiple Myeloma. Decision date: 07/08/2026. Conditional approval